Procholecystokinin and proenkephalin A mRNA expression is modulated by cyclic AMP and noradrenaline

J Mol Endocrinol. 1990 Feb;4(1):37-41. doi: 10.1677/jme.0.0040037.

Abstract

Regulation of the expression of procholecystokinin (proCCK) and proenkephalin A mRNA was studied in the human neuroblastoma cell line SK-N-MC. Cells were treated with dibutyryl-3',5'-cyclic AMP (dbcAMP), noradrenaline or isoproterenol, a beta-adrenoceptor agonist. Levels of proCCK and proenkephalin A mRNA were determined by Northern blot analysis with proCCK- and proenkephalin A-specific cRNA hybridization probes 9 h after drug treatments. ProCCK and proenkephalin A mRNA were co-expressed in SK-N-MC cells. ProCCK mRNA levels were increased 1.5-2.5 times by dbcAMP, noradrenaline and isoproterenol when compared with controls. The level of proenkephalin A mRNA increased approximately two to three times under the same drug conditions, whereas the level of N-myc mRNA did not change significantly. These results suggest that expression of proCCK and proenkephalin A mRNA may be regulated by a similar cAMP-dependent mechanism in the SK-N-MC cell line.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bucladesine / pharmacology
  • Cholecystokinin / genetics*
  • Cyclic AMP / pharmacology*
  • Enkephalins / genetics*
  • Gene Expression / drug effects*
  • Humans
  • Isoproterenol / pharmacology
  • Neuroblastoma / metabolism*
  • Norepinephrine / pharmacology*
  • Nucleic Acid Hybridization
  • Protein Precursors / genetics*
  • RNA Probes
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics*
  • Tumor Cells, Cultured

Substances

  • Enkephalins
  • Protein Precursors
  • RNA Probes
  • RNA, Messenger
  • proenkephalin
  • Bucladesine
  • procholecystokinin
  • Cholecystokinin
  • Cyclic AMP
  • Isoproterenol
  • Norepinephrine